{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:14:39Z","timestamp":1792664079331,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T00:00:00Z","timestamp":1213142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00213-008-1135-6","type":"journal-article","created":{"date-parts":[[2008,6,10]],"date-time":"2008-06-10T08:05:28Z","timestamp":1213085128000},"page":"99-108","source":"Crossref","is-referenced-by-count":52,"title":["Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on l-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat"],"prefix":"10.1007","volume":"199","author":[{"given":"Kristin B.","family":"Dupre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Eskow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Steiniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Klioueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle E.","family":"Negron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Lormand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,11]]},"reference":[{"key":"1135_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/syn.20195","volume":"58","author":"T Antonelli","year":"2005","unstructured":"Antonelli T, Fuxe K, Tomasini MC, Bartoszyk GD, Seyfried CA, Tanganelli S et al (2005) Effects of sarizotan on the corticostriatal glutamate pathways. Synapse 58:193\u2013199","journal-title":"Synapse"},{"key":"1135_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(95)11817-G","volume":"195","author":"R Arai","year":"1995","unstructured":"Arai R, Karasawa N, Geffard M, Nagatsu I (1995) l-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Neurosci Lett 195:195\u2013198","journal-title":"Neurosci Lett"},{"key":"1135_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(96)00252-1","volume":"722","author":"R Arai","year":"1996","unstructured":"Arai R, Karasawa N, Nagatsu I (1996) Dopamine produced from l-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: an immunohistochemical study. Brain Res 722:181\u2013184","journal-title":"Brain Res"},{"key":"1135_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2006.10.020","volume":"1127","author":"M Ba","year":"2006","unstructured":"Ba M, Kong M, Ma G, Yang H, Lu G, Chen S et al (2006) Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of l-DOPA-induced motor complications. Brain Res 1127:177\u2013184","journal-title":"Brain Res"},{"key":"1135_CR5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.20370","volume":"20","author":"W Bara-Jimenez","year":"2005","unstructured":"Bara-Jimenez W, Bibbiani F, Morris MJ, Dimitrova T, Sherzai A, Mouradian MM et al (2005) Effects of serotonin 5-HT1A agonist in advanced Parkinson\u2019s disease. Mov Disord 20:932\u2013936","journal-title":"Mov Disord"},{"key":"1135_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2006.02.003","volume":"23","author":"E Bezard","year":"2006","unstructured":"Bezard E, Gerlach I, Moratalla R, Gross CE, Jork R (2006) 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson\u2019s disease. Neurobiol Dis 23:77\u201386","journal-title":"Neurobiol Dis"},{"key":"1135_CR7","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/WNL.57.10.1829","volume":"57","author":"F Bibbiani","year":"2001","unstructured":"Bibbiani F, Oh JD, Chase TN (2001) Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models. Neurology 57:1829\u20131834","journal-title":"Neurology"},{"key":"1135_CR8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.expneurol.2005.08.017","volume":"196","author":"F Bibbiani","year":"2005","unstructured":"Bibbiani F, Oh JD, Kielaite A, Collins MA, Smith C, Chase TN (2005) Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Exp Neurol 196:422\u2013429","journal-title":"Exp Neurol"},{"key":"1135_CR9","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/j.1460-9568.2006.04790.x","volume":"23","author":"C Bishop","year":"2006","unstructured":"Bishop C, Taylor JL, Kuhn DM, Eskow KL, Park JY, Walker PD (2006) MDMA and fenfluramine reduce l-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation. Eur J Neurosci 23:2669\u20132676","journal-title":"Eur J Neurosci"},{"key":"1135_CR10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/mds.870130507","volume":"13","author":"PJ Blanchet","year":"1998","unstructured":"Blanchet PJ, Konitsiotis S, Chase TN (1998) Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys. Mov Disord 13:798\u2013802","journal-title":"Mov Disord"},{"key":"1135_CR11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2003.07.003","volume":"14","author":"F Calon","year":"2003","unstructured":"Calon F, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T (2003) Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson\u2019s disease. Neurobiol Disord 14:404\u2013416","journal-title":"Neurobiol Disord"},{"key":"1135_CR12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuroscience.2005.09.024","volume":"137","author":"BM Campbell","year":"2006","unstructured":"Campbell BM, Kreipke CW, Walker PD (2006) Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. Neuroscience 137:505\u2013517","journal-title":"Neuroscience"},{"key":"1135_CR13","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","volume":"130","author":"M Carta","year":"2007","unstructured":"Carta M, Carlsson T, Kirik D, Bjorklund A (2007) Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats. Brain 130:1819\u20131833","journal-title":"Brain"},{"key":"1135_CR14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.physbeh.2005.01.019","volume":"84","author":"E Castaneda","year":"2005","unstructured":"Castaneda E, Fleming S, Paquette MA, Boat K, Moffett J, Stachowiak EK et al (2005) Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate. Physiol Behav 84:525\u2013535","journal-title":"Physiol Behav"},{"key":"1135_CR15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","volume":"30","author":"MA Cenci","year":"2007","unstructured":"Cenci MA (2007) Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia. Trends Neurosci 30:236\u2013243","journal-title":"Trends Neurosci"},{"key":"1135_CR16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","volume":"88","author":"JW Chang","year":"1999","unstructured":"Chang JW, Wachtel SR, Young D, Kang UJ (1999) Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson\u2019s disease: studies on medial forebrain bundle and striatal lesions. Neuroscience 88:617\u2013628","journal-title":"Neuroscience"},{"key":"1135_CR17","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1471-1931(00)00018-5","volume":"23","author":"TN Chase","year":"2000","unstructured":"Chase TN, Oh JD (2000) Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci 23:S86\u2013S91","journal-title":"Trends Neurosci"},{"key":"1135_CR18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0028-3908(89)90221-9","volume":"28","author":"AR Crossman","year":"1989","unstructured":"Crossman AR, Peggs D, Boyce S, Luquin MR, Sambrook MA (1989) Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey. Neuropharmacol 28:1271\u20131273","journal-title":"Neuropharmacol"},{"key":"1135_CR19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainres.2007.05.005","volume":"1158","author":"KB Dupre","year":"2007","unstructured":"Dupre KB, Eskow KL, Negron G, Bishop C (2007) The differential effects of 5-HT1A receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat. Brain Res 1158:135\u2013143","journal-title":"Brain Res"},{"key":"1135_CR20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pbb.2007.05.002","volume":"87","author":"KL Eskow","year":"2007","unstructured":"Eskow KL, Gupta V, Alam S, Park JY, Bishop C (2007) The partial 5-HT1A agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Pharmacol Biochem Behav 87:306\u2013314","journal-title":"Pharmacol Biochem Behav"},{"key":"1135_CR21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/1098-2396(20010315)39:4<288::AID-SYN1011>3.0.CO;2-V","volume":"39","author":"D Frechilla","year":"2001","unstructured":"Frechilla D, Cobreros A, Saldise L, Moratalla R, Insausti R, Luquin M et al (2001) Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys. Synapse 39:288\u2013296","journal-title":"Synapse"},{"key":"1135_CR22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.21226","volume":"22","author":"CG Goetz","year":"2007","unstructured":"Goetz CG, Damier P, Hicking C, Laska E, Muller T, Olanow WE et al (2007) Sarizotan as a treatment for dyskinesias in Parkinson\u2019s disease: a double-blind placebo-controlled trial. Mov Disord 22:179\u2013186","journal-title":"Mov Disord"},{"key":"1135_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","volume":"102","author":"PJ Hallett","year":"2004","unstructured":"Hallett PJ, Standaert DG (2004) Rationale for and use of NMDA receptor antagonists in Parkinson\u2019s disease. Pharmacol Ther 102:155\u2013174","journal-title":"Pharmacol Ther"},{"key":"1135_CR24","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1124\/jpet.106.110429","volume":"319","author":"MM Iravani","year":"2006","unstructured":"Iravani MM, Tayarani-Binazir K, Chu WB, Jackson MJ, Jenner P (2006) In MPTP treated primates, the selective 5-HT1a agonist (R)-(+)-8-hydroxy-DPAT inhibits levodopa-induced dyskinesia but only with increased motor disability. J Pharmacol Exp Ther 319:1225\u20131234","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 11","key":"1135_CR25","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20458","volume":"20","author":"J Jankovic","year":"2005","unstructured":"Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson\u2019s disease: clinical manifestations. Mov Disord 20(Suppl 11):S11\u2013S16","journal-title":"Mov Disord"},{"key":"1135_CR26","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1471-4159.2001.00184.x","volume":"76","author":"K Kannari","year":"2001","unstructured":"Kannari K, Yamato H, Shen H, Tomiyama M, Suda T, Matsunaga M (2001) Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation. J Neurochem 76:1346\u20131353","journal-title":"J Neurochem"},{"key":"1135_CR27","first-page":"133","volume":"54","author":"K Kannari","year":"2002","unstructured":"Kannari K, Kurahashi K, Tomiyama M, Maeda T, Arai A, Baba M et al (2002) Tandospirone citrate, a selective 5-HT1A agonist, alleviates l-DOPA-induced dyskinesia in patients with Parkinson\u2019s disease. No To Shinkei 54:133\u2013137","journal-title":"No To Shinkei"},{"key":"1135_CR28","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1471-4159.1986.tb08506.x","volume":"46","author":"IC Kilpatrick","year":"1986","unstructured":"Kilpatrick IC, Jones MW, Phillipson OT (1986) A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation. J Neurochem 46:1865\u20131876","journal-title":"J Neurochem"},{"key":"1135_CR29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.expneurol.2005.06.006","volume":"197","author":"EL Lane","year":"2005","unstructured":"Lane EL, Cheetham SC, Jenner P (2005) Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson\u2019s disease? Exp Neurol 197:284\u2013290","journal-title":"Exp Neurol"},{"key":"1135_CR30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1471-4159.2001.00644.x","volume":"79","author":"JC Lievens","year":"2001","unstructured":"Lievens JC, Salin P, Nieoullon A, Kerkerian-Le Goff L (2001) Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum. J Neurochem 79:893\u2013902","journal-title":"J Neurochem"},{"key":"1135_CR31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.expneurol.2004.01.018","volume":"187","author":"P Loschmann","year":"2004","unstructured":"Loschmann P, De Groote C, Smith L, Wullner U, Fischer G, Kemp JA et al (2004) Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson\u2019s disease. Exp Neurol 187:86\u201393","journal-title":"Exp Neurol"},{"key":"1135_CR32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","volume":"15","author":"M Lundblad","year":"2002","unstructured":"Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease. Eur J Neurosci 15:120\u2013132","journal-title":"Eur J Neurosci"},{"key":"1135_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(03)00295-7","volume":"343","author":"T Maeda","year":"2003","unstructured":"Maeda T, Kannari K, Shen H, Arai A, Tomiyama M, Matsunaga M et al (2003) Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation. Neurosci Lett 343:17\u201320","journal-title":"Neurosci Lett"},{"key":"1135_CR34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(96)00693-2","volume":"736","author":"C Marin","year":"1996","unstructured":"Marin C, Papa S, Engber TM, Bonastre M, Tolosa E, Chase TN (1996) MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats. Brain Res 736:202\u2013205","journal-title":"Brain Res"},{"key":"1135_CR35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2006.07.003","volume":"1112","author":"K Matsubara","year":"2006","unstructured":"Matsubara K, Shimizu K, Suno M, Ogawa K, Awaya T, Yamada T et al (2006) Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions. Brain Res 1112:126\u2013133","journal-title":"Brain Res"},{"key":"1135_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-002-1121-3","volume":"163","author":"L Mignon","year":"2002","unstructured":"Mignon L, Wolf WA (2002) Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat. Psychopharmacology (Berl) 163:85\u201394","journal-title":"Psychopharmacology (Berl)"},{"key":"1135_CR37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00001756-200505120-00009","volume":"16","author":"L Mignon","year":"2005","unstructured":"Mignon L, Wolf WA (2005) 8-Hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson\u2019s disease. Neuroreport 16:699\u2013703","journal-title":"Neuroreport"},{"key":"1135_CR38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00213-006-0680-0","volume":"192","author":"L Mignon","year":"2007","unstructured":"Mignon L, Wolf WA (2007) Postsynaptic 5-HT(1A) receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for Parkinson\u2019s disease. Psychopharmacology (Berl) 192:49\u201359","journal-title":"Psychopharmacology (Berl)"},{"key":"1135_CR39","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1523\/JNEUROSCI.20-20-07782.2000","volume":"20","author":"JE Nash","year":"2000","unstructured":"Nash JE, Brotchie JM (2000) A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson\u2019s disease. J Neurosci 20:7782\u20137789","journal-title":"J Neurosci"},{"key":"1135_CR40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/exnr.1998.6963","volume":"155","author":"JE Nash","year":"1999","unstructured":"Nash JE, Hill MP, Brotchie JM (1999) Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat. Exp Neurol 155:42\u201348","journal-title":"Exp Neurol"},{"key":"1135_CR41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00002826-200403000-00003","volume":"27","author":"CW Olanow","year":"2004","unstructured":"Olanow CW, Damier P, Goetz CG, Mueller T, Nutt J, Rascol O et al (2004) Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). Clin Neuropharmacol 27:58\u201362","journal-title":"Clin Neuropharmacol"},{"key":"1135_CR42","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","volume":"15","author":"M Olsson","year":"1995","unstructured":"Olsson M, Nikkhah G, Bentlage C, Bjorklund A (1995) Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15:3863\u20133875","journal-title":"J Neurosci"},{"key":"1135_CR43","volume-title":"The rat brain in stereotaxic coordinates, 4th edn","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson W (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego"},{"key":"1135_CR44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","volume":"6","author":"B Picconi","year":"2003","unstructured":"Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G et al (2003) Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 6:501\u2013506","journal-title":"Nat Neurosci"},{"key":"1135_CR45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/mds.20394","volume":"20","author":"A Pisani","year":"2005","unstructured":"Pisani A, Centonze D, Bernardi G, Calabresi P (2005) Striatal synaptic plasticity: implications for motor learning and Parkinson\u2019s disease. Mov Disord 20:395\u2013402","journal-title":"Mov Disord"},{"key":"1135_CR46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1590\/S0100-879X2002000200013","volume":"35","author":"CMT Queiroz","year":"2002","unstructured":"Queiroz CMT, Alcantara FB, Yague AML, Bibancos T, Frussa-Filho R (2002) Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice. Braz J Med Biol Res 35:237\u2013242","journal-title":"Braz J Med Biol Res"},{"key":"1135_CR47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A","volume":"417","author":"M Riad","year":"2000","unstructured":"Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X et al (2000) Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 417:181\u2013194","journal-title":"J Comp Neurol"},{"key":"1135_CR48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1460-9568.2004.03591.x","volume":"20","author":"S Robelet","year":"2004","unstructured":"Robelet S, Melon C, Guillet B, Salin P, Kerkerian-LeGoff L (2004) Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson\u2019s disease. E J Neuroscience 20:1255\u20131266","journal-title":"E J Neuroscience"},{"key":"1135_CR49","doi-asserted-by":"crossref","unstructured":"Samadi P, Gregoire L, Morissette M, Calon F, Tahar AH, Dridi M et al (2008) mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiol Dis (in press)","DOI":"10.1016\/j.neurobiolaging.2007.02.005"},{"key":"1135_CR50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1097-4547(19980601)52:5<591::AID-JNR11>3.0.CO;2-5","volume":"52","author":"M Santiago","year":"1998","unstructured":"Santiago M, Matarredona ER, Machado M, Cano J (1998) Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum. J Neurosci Res 52:591\u2013598","journal-title":"J Neurosci Res"},{"key":"1135_CR51","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pbb.2005.06.013","volume":"81","author":"JL Taylor","year":"2005","unstructured":"Taylor JL, Bishop C, Walker PD (2005) Dopamine D1 and D2 receptor contributions to l-DOPA-induced dyskinesia in the dopamine-depleted rat. Pharmacol Biochem Behav 81:887\u2013893","journal-title":"Pharmacol Biochem Behav"},{"key":"1135_CR52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuropharm.2005.12.004","volume":"50","author":"JL Taylor","year":"2006","unstructured":"Taylor JL, Bishop C, Ullrich T, Rice KC, Walker PD (2006) Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not l-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat. Neuropharmacology 50:761\u2013768","journal-title":"Neuropharmacology"},{"key":"1135_CR53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neures.2005.03.004","volume":"52","author":"M Tomiyama","year":"2005","unstructured":"Tomiyama M, Kimura T, Maeda T, Kannari K, Matsunaga M, Baba M (2005) A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to l-DOPA in a rodent model of Parkinson's disease. Neurosci Res 52:185\u2013194","journal-title":"Neurosci Res"},{"key":"1135_CR54","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1097\/00001756-199511000-00030","volume":"6","author":"M Tremblay","year":"1995","unstructured":"Tremblay M, Salin P, Soghomonian JJ (1995) Effect of 6-OHDA lesions on striatal mRNA levels encoding for glutamate receptor subunits. Neuroreport 6:2225\u20132229","journal-title":"Neuroreport"},{"key":"1135_CR55","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.870130307","volume":"13","author":"L Verhagen Metman","year":"1998","unstructured":"Verhagen Metman L, Blanchet PJ, van den Munckhof P, Del Dotto P, Natte R, Chase TN (1998) A trial of extromethorphan in parkinsonian patients with motor response complications. Mov Disord 13:414\u2013417","journal-title":"Mov Disord"},{"key":"1135_CR56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuropharm.2004.03.011","volume":"47","author":"RH Wessell","year":"2004","unstructured":"Wessell RH, Ahmed SM, Menniti FS, Dunbar GL, Chase TN, Oh JD (2004) NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats. Neuropharmacology 47:184\u2013194","journal-title":"Neuropharmacology"},{"key":"1135_CR57","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00001756-200105080-00015","volume":"12","author":"H Yamato","year":"2001","unstructured":"Yamato H, Kannari K, Shen H, Suda T, Matsunaga M (2001) Fluoxetine reduces l-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum. Neuroreport 12:1123\u20131126","journal-title":"Neuroreport"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1135-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1135-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1135-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:06:38Z","timestamp":1558641998000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1135-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,11]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1135-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,11]]}}}